Research progress on artemisinin antimalarial resistance of Plasmodium falciparum
10.13604/j.cnki.46-1064/r.2022.11.17
- Author:
DUAN Meng-xi
;
ZHOU Long-can
;
YANG Zhao-qing
- Publication Type:Journal Article
- Keywords:
Plasmodium falciparum;
artemisinin;
drug resistance;
PfK13;
ring survival assay
- From:
China Tropical Medicine
2022;22(11):1086-
- CountryChina
- Language:Chinese
-
Abstract:
Abstract: Malaria, an infectious disease caused by Plasmodium infection, is one of the most important public health problems worldwide. Artemisinin-based combination therapies (ACTs) are recommended by WHO as the first-line treatment for uncomplicated P. falciparum malaria in malaria-endemic areas. The application of artemisinin and its derivatives has played an integral role in reducing the global incidence of malaria. However, in recent years, the emergence and spread of artemisinin resistance has brought great challenges to global malaria control and elimination. At present, the mutation of K13 gene on chromosome 13 of Plasmodium falciparum is most closely related to artemisinin resistance, but in recent years, studies have shown that K13 cannot explain all artemisinin resistance. This article reviews the recent research progress in the field of artemisinin resistance in Plasmodium falciparum, including definition of artemisinin resistance, detection methods and molecular markers related to resistance. In addition, some of the issues discussed in this review remain controversial and require further study.
- Full text:17.Research progress on artemisinin antimalarial resistance of Plasmodium falciparum.pdf
